Adenosine Receptor-mediated Opening of the BBB for Therapeutic Drug Delivery to the Brain: Proof of Principle for Treatment of Brain Tumors
Principal Investigator: Margaret Bynoe
DESCRIPTION (provided by applicant):
Bynoe’s lab focuses on understanding how the immune system works and the cellular and molecular basis of immune defects that occur in autoimmune diseases and cancer. Her lab also investigates development of immune-based therapies to potentially treat these disorders. Recent work has focused on delivering therapies across the blood-brain barrier.